Rebel Medicine
- Biotech or pharma, therapeutic R&D
- Biotech or pharma, animal health
Rebel Medicine is advancing a proprietary injectable drug delivery platform that significantly extends the duration and therapeutic effect of injectable and locally administered drugs from days to months. Our lead program is a long-acting local anesthetic designed to locally control postoperative pain for days and mitigate the use of opioids after surgery. Pipeline programs include once-monthly delivery of incretin peptides for metabolic diseases. Our versatile delivery technologies are broadly applicable across multiple drug classes, offering partnership opportunities to unlock long-acting potential in both new and existing therapeutics.